Murat Topbas

Prof. Dr. Murat Topbas

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2008 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MSMehmet Sonmez
Mehmet Sonmez
TATulin Akagun
Tulin Akagun
MTMurat Topbas
Murat Topbas
UCUmit Cobanoglu
Umit Cobanoglu
BSBircan Sonmez
Bircan Sonmez
SOSerdar Bedii Omay
Serdar Bedii Omay
Multiple Myeloma (MM) is a B cell neoplasm characterized by the clonal proliferation of plasma cells. Skeletal complications are found in up to 80% of myeloma patients at presentation and are major cause of morbidity.

30 May 2008 in Respiratory Research
Verified
Journal Article
Open access
PDF file
STSuleyman Turedi
Suleyman Turedi
AGAbdulkadir Gunduz
Abdulkadir Gunduz
AMAhmet Mentese
Ahmet Mentese
MTMurat Topbas
Murat Topbas
SKSuleyman C Karahan
Suleyman C Karahan
RRRobert M Russell
Robert M Russell
The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, the sensitivity and specificity of IMA is compared with D-dimer both with and without clinical probability scores in patients with suspected PE. Consecutive patients presenting to the emergency department with suspected PE were prospectively recruited, and healthy volunteers were also enrolled as controls. D-dimer and IMA levels were measured for the entire study group. Wells and Geneva scores were calculated and s-CTPA was performed on all suspected PE patients. The study population consisted of 130 patients with suspected PE and 59 healthy controls. Mean IMA levels were 0.362 +/- 0.11 ABSU for Group A, the PE group (n = 75); 0.265 +/- 0.07 ABSU for Group B, the non-PE group (n = 55); and 0.175 +/- 0.05 ABSU for Group C, the healthy control group (p < 0.0001). At a cut-off point of 0.25 ABSU, IMA was 93% sensitive and 75% specific in the diagnosis of PE. PPV was 79.4% and NPV was 78.6%. Mean D-dimer levels were 12.48 +/- 10.88 microg/ml for Group A; 5.36 +/- 7.80 microg/ml for Group B and 0.36 +/- 0.16 microg/ml for Group C (p < 0.0001). The D-dimer cut-off point was 0.81 microg/ml with a sensitivity of 98.9% and a specificity of 62.7%, PPV of 69.4% and NPV of 83.3%. The use of IMA in combination with Wells and Geneva clinical probability scores was determined to have a positive impact on these scores' sensitivity and negative predictive values. IMA is a good alternative to D-dimer in PE diagnosis in terms of both cost and efficiency. Used in combination with clinical probability scores, it has a similar positive effect on NPV and sensitivity to that of D-dimer. The PPV of IMA is better than D-dimer, but it is still unable to confirm a diagnosis of PE without additional investigation.

19 February 2020 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
AGArzu Erden Güner
Arzu Erden Güner
EAElif Acar Arslan
Elif Acar Arslan
BDB. Dündar
B. Dündar
MTMurat Topbas
Murat Topbas
UCU. Cavlak
U. Cavlak

6 September 2020 in Environmental Management
Verified
Journal Article
Closed access
PDF file
LKLatife Köker
Latife Köker
FAFatih Aydın
Fatih Aydın
ÖGÖzcan Gaygusuz
Özcan Gaygusuz
RAReyhan Akcaalan
Reyhan Akcaalan
DÇDerya Çamur
Derya Çamur
MAMeriç Albay
Meriç Albay


7 December 2020 in Environmental Management
Verified
Journal Article
Closed access
PDF file
DÇDerya Çamur
Derya Çamur
MTMurat Topbas
Murat Topbas
HIHüseyin İlTer
Hüseyin İlTer
MAMeriç Albay
Meriç Albay
FAFerruh Niyazi Ayoğlu
Ferruh Niyazi Ayoğlu
BABilgehan Açıkgöz
Bilgehan Açıkgöz